Fifth Pillar of Cancer Treatment

Dedicated to Providing the most Innovative CAR T Therapy to Patients Today….

For Patients that can’t wait for Tomorrow.

Gold Ribbon
774647_edited.jpg

MINIMALLY INVASIVE PROCEDURE

Oasis has established an advanced technological platform of clinical-grade CAR-T cell preparation, developed a number of candidate CAR-T cellular products, and continuously optimized this technological platform to develop the next generation of CAR-T cellular products.  Products include Car-T for Cancer and Car-T for Covid-19. We continue to be at the forefront of a powerful form of immunotherapy known as chimeric antigen receptor (CAR) T cell therapy.  Using this approach, immune cells are taken from a patient’s bloodstream, reprogrammed to recognize and attack a specific protein found in cancer cells, then reintroduced into the patient’s system, where they get to work destroying targeted tumor cells.

Want to learn more about the latest in cellular therapies?